RIS Rx, a healthcare technology company that helps pharmaceutical manufacturers improve how they manage patient payment support, has announced the appointment of John Driscoll as Chairman of its Board of Directors. With a long-standing career across various areas of healthcare, Driscoll brings significant expertise in operations, strategy, and leading growth for organizations involved in care delivery, insurance, and health technology.
Health Technology Insights: Humana’s 2026 Medicare Advantage Plans Focus on Quality Care
Driscoll most recently served as Executive Vice President and President of U.S. Healthcare at Walgreens Boots Alliance after its acquisition of CareCentrix, where he had spent nearly ten years as CEO. Under his leadership, CareCentrix became a recognized name in home-based and post-acute care. Earlier in his career, he helped shape Castlight Health, held a senior leadership role at Medco, and played a key role in establishing Surescripts, a national e-prescribing network. He currently serves as Independent Chairman at Waystar, a healthcare payments platform listed on Nasdaq, and also chairs the boards at UConn Health and Magnit Global.
Health Technology Insights: InteropKey and Corista Unite for Value-Based Care Growth
Gerard Rivera, CEO and Co-Founder of RIS Rx, said that Driscoll’s appointment comes at an important time for the company. He explained that RIS Rx was created to bring clarity and integrity to the process by which pharmaceutical companies ensure financial support reaches patients. Rivera noted that Driscoll’s leadership, along with his experience growing purpose-driven companies in complex environments, will be key as RIS Rx moves into its next stage of expansion.
John Driscoll expressed enthusiasm about joining RIS Rx during a critical phase of its growth. He pointed out that the company’s technology addresses one of the industry’s most persistent issues—making sure that patient financial assistance actually reaches those who need it. Driscoll said he is eager to work alongside Rivera, the management team, and the board to help strengthen the company’s position and drive continued innovation.
RIS Rx continues to focus on building scalable technology solutions that solve real-world challenges in the pharmaceutical payment ecosystem. With Driscoll stepping into the Chairman role, the company looks to deepen its impact in ensuring patients benefit from the support intended for them, while enabling pharmaceutical manufacturers to reduce inefficiencies and improve outcomes.
Health Technology Insights: Pharmanovia Appoints Stephan Eder as Chief Executive Officer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
